SCHEMBL13710198

SCHEMBL13710198

Cc1sc(-c2ccc(C(F)(F)F)cc2)nc1C1=C(O)CC(C)(C)CC1=O

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ WRN Q14191 4/20 0.49
▸ MAPT P10636 3/20 0.41
▸ KDM4E B2RXH2 2/20 0.41
▸ MEN1 O00255 1/20 0.41
▸ HSP90AA1 P07900 1/20 0.41
▸ CRHBP P24387 1/20 0.41
▸ KMT2A Q03164 1/20 0.41
▸ CRHR2 Q13324 1/20 0.41
▸ ALDH1A1 P00352 3/20 0.40
▸ NPC1 O15118 2/20 0.40
▸ GAA P10253 2/20 0.40
▸ PIK3CD O00329 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ PIK3CB P42338 1/20 0.40
▸ PIK3CG P48736 1/20 0.40
▸ MAPK1 P28482 2/20 0.39
▸ CYP11B2 P19099 1/20 0.38
▸ RAB9A P51151 1/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ RARA P10276 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13710191 0.88 PIK3CD (0.41) WRNMAPTKDM4EMEN1KMT2A
SCHEMBL13710236 0.85 WRN (0.47) WRNMAPTKDM4EKMT2AALDH1A1
SCHEMBL13710209 0.85 RARA (0.48) WRNMAPTMEN1KMT2AALDH1A1
SCHEMBL13761069 0.83 MAPT (0.40) WRNMAPTKDM4EMEN1HSP90AA1
SCHEMBL13710172 0.77 KMT2A (0.44) WRNKDM4EKMT2AALDH1A1NPC1
SCHEMBL13710187 0.73 RARA (0.42) WRNALDH1A1RARARARBRARG
SCHEMBL13710221 0.70 APEX1 (0.44) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL13710176 0.70 PTGDR2 (0.47) WRNMAPTKDM4EMEN1KMT2A
SCHEMBL9629255 0.70 KDM4E (0.59) MAPTKDM4EMEN1HSP90AA1CRHBP
SCHEMBL13710195 0.70 RARA (0.49) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-7595404-B2 Thiazolyl-substituted carbocyclic 1,3-diones as pesticidal agents BAYER CROPSCIENCE AG (DE) 2009-09-29 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents BAYER INTELLECTUAL PROPERTY GMBH (DE) 2007-06-14 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135630-A1 Thiazolyl-substsituted carbocylic 1,3-diones as pesticidal agents DDT, CYP4B1, CYP1B1 WRN 3013/4885MAPT 4528/4885KDM4E 1623/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback